Frank Buchholz shares how his laboratory improves upon the latest gene editing techniques by designing programmable ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

Scientists used CRISPR to reactivate uricase, an enzyme humans lost millions of years ago. Restoring the gene in liver cells ...

The results suggest that lung xenotransplantation could one day become an option, but they also point to how much more work ...

There were more than 48,000 organ transplants in the U.S. in 2024, a 3.3% increase from 2023, according to Organ Procurement ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of ...

Scientists have recently reported on the results of a universal cancer vaccine that boosts the immune system to fight tumors ...

The field of plant biotechnology is experiencing a revolution with the advent of advanced genome editing tools and ...

Research Topic Highlights<br/><br/>This collection highlights recent advances, potential, and challenges associated with emerging biotechnologies in agriculture, emphasizing the significant impact of ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of “genetic surgery” is performed on DNA, for ...

Researchers demonstrate the active role methyl groups play in silencing genes, demonstrating the therapeutic potential of ...